These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 15678599

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
    Bockhorn M, Frilling A, Rewerk S, Liedke M, Dirsch O, Schmid KW, Broelsch CE.
    Thyroid; 2004 Jun; 14(6):468-70. PubMed ID: 15242577
    [Abstract] [Full Text] [Related]

  • 4. [Increased blood CEA level as initial manifestation of medullary thyroid carcinoma].
    Behr TM, Becker W.
    Dtsch Med Wochenschr; 1999 Mar 12; 124(10):303-4. PubMed ID: 10191829
    [No Abstract] [Full Text] [Related]

  • 5. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
    Miyauchi A, Onishi T, Matsuzuka F, Hirai K, Kuma K, Takai S, Nakamoto K, Nakamura K, Nanjo S, Maeda M.
    Gan No Rinsho; 1986 Oct 12; 32(12):1519-24. PubMed ID: 3783976
    [Abstract] [Full Text] [Related]

  • 6. Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumors.
    Pichon MF, Coquin G, Fauveau C, Rey A.
    Anticancer Res; 1999 Oct 12; 19(2B):1445-50. PubMed ID: 10365121
    [Abstract] [Full Text] [Related]

  • 7. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
    Argémi B, Vagneur JP, Conforto C, Even F, Rollat MC, Simonin R.
    Bull Cancer; 1984 Oct 12; 71(2):133-9. PubMed ID: 6733293
    [Abstract] [Full Text] [Related]

  • 8. Calcitonin-like polypeptides without apparent biological activity in a patient with recurrent medullary thyroid carcinoma.
    Nakajima K, Jinkawa I, Hirota T, Ikeda T, Tugawa M, Minami Y, Hanada M.
    Intern Med; 1995 Sep 12; 34(9):896-900. PubMed ID: 8580565
    [Abstract] [Full Text] [Related]

  • 9. [High carcinoembryonic antigen level following cancer surgery: another way to detect thyroid medullary carcinoma].
    Martinez M, Virally ML, Guillausseau-Scholer C, Vincenot M, Samuel-Lajeunesse J, Mauvais-Jarvis F, Kévorkian JP, Porokhov B, Valleur P, Guillausseau PJ.
    Rev Med Interne; 2000 Oct 12; 21(10):897-900. PubMed ID: 11075399
    [Abstract] [Full Text] [Related]

  • 10. Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy.
    Hajje G, Borget I, Leboulleux S, Chougnet C, Al Ghuzlan A, Mirghani H, Caramella C, Hartl D, Schlumberger M, Baudin E.
    Eur J Endocrinol; 2013 Feb 12; 168(2):113-8. PubMed ID: 23093698
    [Abstract] [Full Text] [Related]

  • 11. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
    Cox CE, VanVickle J, Froome LC, Mendelsohn G, Baylin SB, Wells SA.
    Surg Forum; 1979 Feb 12; 30():120-1. PubMed ID: 395674
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum calcitonin-negative medullary thyroid carcinoma: role of CgA and CEA as complementary markers.
    Giovanella L, Crippa S, Cariani L.
    Int J Biol Markers; 2008 Feb 12; 23(2):129-31. PubMed ID: 18629788
    [Abstract] [Full Text] [Related]

  • 14. Somatostatin analogs in the treatment of medullary thyroid carcinoma.
    Díez JJ, Iglesias P.
    J Endocrinol Invest; 2002 Oct 12; 25(9):773-8. PubMed ID: 12398235
    [Abstract] [Full Text] [Related]

  • 15. Chronic diarrhea: The first symptom of a metastatic medullary thyroid carcinoma.
    Ernaga Lorea A, Migueliz Bermejo I, Eguílaz Esparza N, Hernández Morhain MC, Pineda Arribas J.
    Gastroenterol Hepatol; 2018 Feb 12; 41(2):105-107. PubMed ID: 28259364
    [No Abstract] [Full Text] [Related]

  • 16. The use of octreotide in the treatment of medullary thyroid carcinoma.
    Frank-Raue K, Ziegler R, Raue F.
    Horm Metab Res Suppl; 1993 Feb 12; 27():44-7. PubMed ID: 8330871
    [Abstract] [Full Text] [Related]

  • 17. Rising carcinoembryonic antigen during follow-up for colonic carcinoma--an unusual presentation of medullary carcinoma of the thyroid.
    Breeze J, McKinna F, Howlett DC.
    Clin Oncol (R Coll Radiol); 2008 Jun 12; 20(5):382. PubMed ID: 18374551
    [No Abstract] [Full Text] [Related]

  • 18. Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma.
    Ide A, Ashizawa K, Ishikawa N, Ishii R, Ando T, Abe Y, Sera N, Usa T, Tominaga T, Ejima E, Nakashima M, Ito K, Ito K, Eguchi K.
    Thyroid; 2001 Nov 12; 11(11):1055-61. PubMed ID: 11762716
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Severely elevated and persistent circulating carcinoembryonic antigen without discernible cancer].
    Woodtli W, Ziegler W, Dambacher M.
    Schweiz Med Wochenschr; 1982 Mar 06; 112(10):352-3. PubMed ID: 7079681
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.